Pulse Biosciences, Inc. Operating Lease Right-of-Use Assets
Pulse Biosciences, Inc. (PLSE) had Operating Lease Right-of-Use Assets of $5.38 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Operating Lease, Right-of-Use Asset $5.38M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $5.70M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $6.01M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $6.32M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $5.38M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $5.70M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $6.01M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $6.32M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $6.32M 10-Q · filed 2025-11-05 | $6.61M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $6.89M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $7.16M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $6.59M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $6.82M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $7.04M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $7.26M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $7.47M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $7.67M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $7.87M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $8.06M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $8.25M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $8.43M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $8.61M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $7.26M 10-Q · filed 2024-10-30 | $8.79M 10-K · filed 2022-03-31 |
| 2021-09-30 | $8.95M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $9.12M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $9.28M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $9.44M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $9.60M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $9.75M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $5.04M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $5.11M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $1.19M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.18M 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |